Suzuki T, Izumi H, Ohno M.

	Figure 1. Transport of Cy3-labeled U1δSm RNA microinjected into the Xenopus oocyte nuclei. (A) In vitro–transcribed Cy3-labeled m7G-capped U1δSm RNA was microinjected into Xenopus oocyte nuclei that had been cytoplasmically preinjected with Cy5-labeled U7 RNA as a marker of Cajal Bodies 12 h earlier. The nuclei were manually isolated under mineral oil at 1 (left), 3 (middle), and 6 h (right) after injection. The nuclei were observed by fluorescent microscopy as described in Materials and methods. Red, Cy3-U1δSm; yellow, Cy5-U7. The arrows and the dotted lines represent Cajal bodies and the nuclear envelope, respectively. Bars, 20 µm. (B) A mixture of in vitro–transcribed Cy3-labeled U1δSm and FITC-labeled U6δss RNAs was microinjected into the Xenopus oocyte nuclei. RNA was extracted from nuclear (N) and cytoplasmic (C) fractions 1, 3, and 6 h after microinjection and analyzed by 8% denaturating PAGE followed by Typhoon scan. (C) Xenopus oocytes were fractionated into Nsup, Nppt, and cyctoplasmic fractions as described in Materials and methods. Western blotting was performed with total oocyte (total), Nsup, Nppt, and cytoplasmic fractions using antibodies against coilin, PHAX, and U2B”. Each lane was loaded with materials from 2.5 oocytes. (D) Northern blotting was performed with RNA prepared from total, Nsup, Nppt, and cytoplasmic fractions using probes against U3 snoRNA and 5.8S rRNA. Each lane was loaded with RNA from 2.5 oocytes. nt, nucleotide. (E) A mixture of 32P-labeled m7G-capped U1δSm, m7G-capped U5δSm, U6δss, and initiator methionyl tRNA was injected into the nucleus of Xenopus oocytes. RNA was extracted from Nsup, Nppt, and cytoplasmic fractions immediately at 0 (lanes 1–3) 1 (lanes 4–6), 2 (lanes 7–9), 3 (lanes 10–12), and 6 h (lanes 13–15) after microinjection and analyzed by 8% denaturating PAGE followed by autoradiography. (F and G) Quantification of the radioactivity of U1 and U5 bands in E, respectively. Yellow, C fraction; red, Nsup fraction; blue, Nppt fraction. Black lines indicate that intervening lanes have been spliced out.
	Figure 2. Effect of anti-PHAX antibody on the distribution of injected U snRNA precursors. (A) A mixture of 32P-labeled m7G-capped U1δSm, m7G-capped U5δSm, and U6δss was injected into the nucleus of Xenopus oocytes either alone (lanes 1–6) or together with 0.42 µg/oocyte WGA (lanes 7–9), 33 ng/oocyte control (ctr) IgG (lanes 10–12), or anti-PHAX antibody (lanes 13–15), WGA and control IgG (lanes 16–18), or WGA and anti-PHAX antibody (lanes 19–21). RNA was extracted and analyzed as in Fig.1 E at 0 and 2 h after injection. C, cytoplasmic fraction. (B) A 32P-labeled m7G-capped U1δSm was incubated either alone (lane 1) or together with 1 µM recombinant CBC (lane 2), 1 µM of each recombinant CBC and PHAX (lane 3), or CBC and PHAX and affinity-purified anti-PHAX antibody (lane 4) for 20 min at 25°C. The samples were fractionated by native 6% PAGE followed by autoradiography. Free RNA and major complexes are indicated on the right. Black lines indicate that intervening lanes have been spliced out. (C and D) The radioactivity of the bands of U1δSm and U5δSm RNAs, respectively, was quantified from three independent experiments as in A, and the ratio of the Nppt signal against the nuclear fraction total (Nppt + Nsup) signal was calculated. The means and standard deviations for WGA alone, WGA + control, IgG, and WGA + anti-PHAX antibody are shown. (E) The distribution of Cy3-labed m7G-capped U1δSm RNA was analyzed as in Fig.1 A at 2 h after microinjection in the presence of WGA + affinity-purified anti-PHAX antibody (right) or WGA + control (control) IgG (left). Bars, 20 µm.
	Figure 3. Effect of PHAX mutant proteins on the distribution of injected U snRNA precursors. (A) Schematic representation of the domain structures of human PHAX protein and the features of the PHAX mutants used in this study. The numbers represent the amino acid numbers of the PHAX protein. WT, wild type. (B) The same mixture of 32P-labeled RNAs as in Fig. 2 A was injected into the nuclei of Xenopus oocytes either alone (lanes 1–6) or together with 25 ng/oocyte of recombinant PHAXδCD (δCD; lanes 7–9), PHAXδN (δN; lanes 10–12), PHAXδNES (δNES; lanes 13–15), PHAXδST2 (δST2; lanes 16–18), WGA and δCD (lanes 19–21), WGA and δN (lanes 22–24), WGA and δNES (lanes 25–27), or WGA and δST2 (lanes 28–30). RNA was analyzed as in Fig. 2 A. (C and D) The ratio of the Nppt signal against the nuclear fraction total signal of U1δSm and U5δSm, respectively, was calculated from three independent experiments as in A. The means and standard deviations for WGA + δCD, WGA + δN, WGA + δNES, and WGA + δST2 are shown. (E) The same RNA mixture was injected with either WGA + δCD (lanes 1–9), WGA + δN (lanes 10–18), or WGA + δNES (lanes 19–27). RNA was analyzed at 0, 1.5, and 3 h as in (A). (F) The distribution of Cy3-labeled m7G-capped U1δSm RNA was analyzed as in Fig. 1 A at 2 h after microinjection in the presence of WGA + δN (right) or WGA + δCD (left). C, cytoplasmic fraction. Bars, 20 µm.
	Figure 4. Effect of CRM1 inhibition on the distribution of injected U snRNA precursors. (A) The same mixture of 32P-labeled RNAs as in Fig. 2 A was injected into the nuclei of Xenopus oocytes either alone (lanes 1–6) or together with ΔCD (lanes 7–9), ΔN (lanes 10–12), 0.3 µg/oocyte BSAmut (lanes 13–15), BSAmut + ΔCD (lanes 16–18), BSAmut + ΔN (lanes 19–21), 0.3 µg/oocyte BSA-NES (lanes 22–24), BSA-NES + ΔCD (lanes 25–27), or BSA-NES + ΔN (lanes 28–30). RNA was analyzed as in Fig. 2 A. (B and C) The ratio of the Nppt signal against the nuclear fraction total signal of U1ΔSm and U5ΔSm, respectively, was calculated from three independent experiments as in A. The means and standard deviations for BSA-NES alone, BSA-NES + ΔCD, and BSA-NES + ΔN are shown. C, cytoplasmic fraction.
	Figure 5. Effect of the inhibitors on the distribution of in vivo–transcribed U snRNAs. A mixture of the plasmids harboring the U1ΔSm and U2ΔSm genes was microinjected into the nuclei of Xenopus oocytes either alone (lanes 1–3) or together with control (ctr) IgG (lanes 4–6), anti-PHAX antibody (lanes 7–9), ΔCD protein (lanes 10–12), ΔN protein (lanes 13–15), or ΔNES protein (lanes 16–18), and the nucleocytoplasmic distribution of the transcripts was analyzed by Northern blotting of the Nsup, Nppt, and cytoplasmic (C) RNA fractions after 1.5 h. Black lines indicate that intervening lanes have been spliced out. (B and C) The ratio of the Nppt signal against the nuclear fraction total signal of U1ΔSm and U2ΔSm, respectively, was calculated from three independent experiments as in A. The means and the standard deviations for WGA+ctr IgG, WGA+anti-PHAX antibody, WGA+ΔCD, WGA+ΔN, and WGA+ΔNES are shown.
	Figure 6. Model for the transport of U snRNA from genes to cytoplasm. See Results for details.

Abbott, The stem-loop binding protein (SLBP1) is present in coiled bodies of the Xenopus germinal vesicle. 1999, Pubmed, Xenbase

Abbott, The stem-loop binding protein (SLBP1) is present in coiled bodies of the Xenopus germinal vesicle. 1999, Pubmed , Xenbase
Boulon, PHAX and CRM1 are required sequentially to transport U3 snoRNA to nucleoli. 2004, Pubmed
Chari, The role of RNP biogenesis in spinal muscular atrophy. 2009, Pubmed
Cioce, Cajal bodies: a long history of discovery. 2005, Pubmed
Dundr, Actin-dependent intranuclear repositioning of an active gene locus in vivo. 2007, Pubmed
Fischer, The HIV-1 Rev activation domain is a nuclear export signal that accesses an export pathway used by specific cellular RNAs. 1995, Pubmed
Fornerod, CRM1 is an export receptor for leucine-rich nuclear export signals. 1997, Pubmed , Xenbase
Frey, Coiled bodies contain U7 small nuclear RNA and associate with specific DNA sequences in interphase human cells. 1995, Pubmed
Frey, RNA-mediated interaction of Cajal bodies and U2 snRNA genes. 2001, Pubmed
Frey, Association of snRNA genes with coiled bodies is mediated by nascent snRNA transcripts. 1999, Pubmed
Fuke, Role of poly (A) tail as an identity element for mRNA nuclear export. 2008, Pubmed , Xenbase
Fukuda, CRM1 is responsible for intracellular transport mediated by the nuclear export signal. 1997, Pubmed , Xenbase
Gall, Lampbrush chromosomes. 1991, Pubmed , Xenbase
Gao, Human genes encoding U3 snRNA associate with coiled bodies in interphase cells and are clustered on chromosome 17p11.2 in a complex inverted repeat structure. 1997, Pubmed
Hamm, An abundant U6 snRNP found in germ cells and embryos of Xenopus laevis. 1989, Pubmed , Xenbase
Huber, Snurportin1, an m3G-cap-specific nuclear import receptor with a novel domain structure. 1998, Pubmed , Xenbase
Izaurralde, A cap-binding protein complex mediating U snRNA export. 1995, Pubmed , Xenbase
Izaurralde, A nuclear cap binding protein complex involved in pre-mRNA splicing. 1994, Pubmed , Xenbase
Jacobs, Coiled bodies preferentially associate with U4, U11, and U12 small nuclear RNA genes in interphase HeLa cells but not with U6 and U7 genes. 1999, Pubmed
Jády, Modification of Sm small nuclear RNAs occurs in the nucleoplasmic Cajal body following import from the cytoplasm. 2003, Pubmed
Jarmolowski, Nuclear export of different classes of RNA is mediated by specific factors. 1994, Pubmed , Xenbase
Kataoka, Identification of the factors that interact with NCBP, an 80 kDa nuclear cap binding protein. 1995, Pubmed
Kitao, A compartmentalized phosphorylation/dephosphorylation system that regulates U snRNA export from the nucleus. 2008, Pubmed , Xenbase
Kolb, Molecular functions of the SMN complex. 2007, Pubmed
Massenet, The SMN complex is associated with snRNPs throughout their cytoplasmic assembly pathway. 2002, Pubmed
Masuyama, RNA length defines RNA export pathway. 2004, Pubmed , Xenbase
Matera, Non-coding RNAs: lessons from the small nuclear and small nucleolar RNAs. 2007, Pubmed
Nesic, A role for Cajal bodies in the final steps of U2 snRNP biogenesis. 2004, Pubmed
Ohno, PHAX, a mediator of U snRNA nuclear export whose activity is regulated by phosphorylation. 2000, Pubmed , Xenbase
Ohno, A nuclear cap binding protein from HeLa cells. 1990, Pubmed
Ossareh-Nazari, Evidence for a role of CRM1 in signal-mediated nuclear protein export. 1997, Pubmed
Patel, The assembly of a spliceosomal small nuclear ribonucleoprotein particle. 2008, Pubmed
Patel, Live images of RNA polymerase II transcription units. 2008, Pubmed , Xenbase
Renvoisé, The loss of the snoRNP chaperone Nopp140 from Cajal bodies of patient fibroblasts correlates with the severity of spinal muscular atrophy. 2009, Pubmed
Schaffert, RNAi knockdown of hPrp31 leads to an accumulation of U4/U6 di-snRNPs in Cajal bodies. 2004, Pubmed
Schul, Coiled bodies and U2 snRNA genes adjacent to coiled bodies are enriched in factors required for snRNA transcription. 1998, Pubmed
Segref, The evolutionarily conserved region of the U snRNA export mediator PHAX is a novel RNA-binding domain that is essential for U snRNA export. 2001, Pubmed , Xenbase
Smith, U2 and U1 snRNA gene loci associate with coiled bodies. 1995, Pubmed
Smith, Interactions of U2 gene loci and their nuclear transcripts with Cajal (coiled) bodies: evidence for PreU2 within Cajal bodies. 2000, Pubmed
Stade, Exportin 1 (Crm1p) is an essential nuclear export factor. 1997, Pubmed
Stanek, The Cajal body: a meeting place for spliceosomal snRNPs in the nuclear maze. 2006, Pubmed
Stanĕk, Detection of snRNP assembly intermediates in Cajal bodies by fluorescence resonance energy transfer. 2004, Pubmed
Vankan, Domains of U4 and U6 snRNAs required for snRNP assembly and splicing complementation in Xenopus oocytes. 1990, Pubmed , Xenbase
Watkins, Involvement of nuclear import and export factors in U8 box C/D snoRNP biogenesis. 2007, Pubmed
Wen, Identification of a signal for rapid export of proteins from the nucleus. 1995, Pubmed
Will, Spliceosomal UsnRNP biogenesis, structure and function. 2001, Pubmed
Wu, The Sm binding site targets U7 snRNA to coiled bodies (spheres) of amphibian oocytes. 1996, Pubmed , Xenbase
Young, The relationship between SMN, the spinal muscular atrophy protein, and nuclear coiled bodies in differentiated tissues and cultured cells. 2000, Pubmed
Yu, Internal modification of U2 small nuclear (sn)RNA occurs in nucleoli of Xenopus oocytes. 2001, Pubmed , Xenbase